Pugatch Consilium releases new edition of Building the Bioeconomy – Shows how economies that are successful in building a high-tech biotechnology capacity put the right enabling policies in place

Posted by:

Commissioned by the Biotechnology Industry Organization and authored by Pugatch Consilium this series of reports seek to provide an overview of those national innovation strategies, policies and best practices that have been successful in creating an environment in which biotechnologies and biotechnological innovation can flourish.

 

This year Building the Bioeconomy has grown from thirteen economies to sixteen, adding Colombia, Israel and Japan. As in previous editions the sample of economies is geographically and economically diverse with a mix of high-income mature ...

Continue Reading →
0

Separating Fact from Fiction – How Localization Barriers Fail Where Positive Non-discriminatory Incentives Succeed

Posted by:

More in number and more draconian – Localization barriers have grown in number and intensity over the last decade. Our new study – Separating Fact from Fiction: How Localization Barriers Fail Where Positive Non-discriminatory Incentives Succeed – finds that over the last 5-10 years industrial aspirations and concern over their dependence on global supply chains have led many emerging markets to seek to bolster or create indigenous sectors through introducing protectionist-like measures.

However, the study also finds that restrictive and punitive ...

Continue Reading →
0

Pugatch Consilium at the Mexican Senate and IMPI event on promoting economic development and industrial competitiveness in Mexico

Posted by:

Dr. David Torstensson spoke yesterday at the Mexican Senate and IMPI (the Mexican industrial property institute) event entitled: “First day for an original Mexico – promoting the culture of industrial property” (Primera Jornada por un México Original: Promoviendo la cultura de la propiedad industrial). With the aim of increasing awareness to the importance of IP protection to economic development, numerous representatives of public and private institutions analyzed the current state of the Mexican IP environment, with a particular focus on ...

Continue Reading →
0

Infinite Possibilities

Posted by:

Professor Meir Pugatch spoke at the launch of the fourth edition of the U.S. Chamber’s International IP Index. Titled: Infinite Possibilities, this edition maps and benchmarks the intellectual property environment in 38 economies, which together account for nearly 85% of global gross domestic product (GDP). On the whole, while challenges and setbacks still exist across the board, many of the benchmarked countries have taken positive steps and improved their IP environments. The Index also includes a special annex which underscores ...

Continue Reading →
0

Pugatch Consilium at the New Delhi conference on Expanding Healthcare Access in India

Posted by:

Last thursday January 14, 2016, Prof Meir Pugatch spoke at the groundbreaking conference entitled “Growing the Innovative Bio-pharmaceutical Industry and Expanding Healthcare Access in India” in New Delhi convened by the The U.S.-India Business Council (USIBC) in partnership with the Department of Industrial Policy and Promotion (DIPP) and the Investment and Technology Promotion Division (ITP) of the Ministry of External Affairs. During the session, Prof Pugatch presented the findings of one of Pugatch Consilium’s latest studies on India, highlighting how ...

Continue Reading →
0

The Next Frontier in Ensuring the Quality of Medicines: Maintaining International Quality and Safety Standards in the Manufacturing and Supply of Active Pharmaceutical Ingredients

Posted by:

Today Pugatch Consilium launches The Next Frontier in Ensuring the Quality of Medicines: Maintaining International Quality and Safety Standards in the Manufacturing and Supply of Active Pharmaceutical Ingredients. Authored by Professor Meir Pugatch, Dr. David Torstensson and Ma’ayan Laufer this report provides a deep-dive analysis of the next generation of challenges facing drug regulators across the globe.

Pharmacovigilance is the name given to the mechanisms and tests that together map and ensure the safety of a medicine throughout its life span ...

Continue Reading →
0

Pugatch Consilium at the International BIO Convention

Posted by:

Yesterday, June 16th 2015, Prof Meir Pugatch presented the findings of two of Pugatch Consilium’s latest studies at an opening plenary session of the International BIO Convention in Philadelphia, Pennsylvania. During the session, Prof Pugatch discussed empirical measures of national biopharmaceutical environments, including the Biopharmaceutical Competitiveness & Investment (BCI) Survey and Building the Bioeconomy 2015, and how these tools can be used to shed light on emerging opportunities and challenges in global biotech markets.

 

The results of the two studies are also being presented in additional panels ...

Continue Reading →
0

New Study: Policy Environment Has a Significant Impact on Biopharmaceutical Investment

Posted by:

Economies’ policy trajectories have a significant impact on biopharmaceutical investment decisions, perhaps more than costs and market size, according to local executives. Our new study, Measuring the Global Biomedical Pulse: The Biopharmaceutical Investment & Competitiveness (BCI) Survey, finds that economies with policy environments that support investment and innovation rank as the most attractive for biopharmaceutical investment in the eyes of top level executives operating on the ground. The study, commissioned by PhRMA, also finds that notwithstanding low costs and considerable ...

Continue Reading →
0

PUGATCH CONSILIUM LAUNCHES NEW REPORT ON BUILDING THE BIOECONOMY

Posted by:

Today Pugatch Consilium launches Building the Bioeconomy 2015 the second edition study of the policies and best practices that pave the way for a creating an environment and ecosystem that enables biotech innovation. The 2015 edition focuses on 13 countries: Brazil, China, India, Korea, Malaysia, Mexico, Russia, Singapore, South Africa, Switzerland, Turkey, the UK and the United States. Using a comparative perspective and looking in detail at the country specific-level, the report identifies several important findings as well as lessons learned.

 

The report identifies ...

Continue Reading →
0
Page 4 of 15 «...23456...»